Related Experiment Video
Updated: Jul 19, 2026
08:33
Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
Specific binding of a hexanucleotide to HIV-1 reverse transcriptase: a novel class of bioactive molecules
Alessandra Mescalchin1, Winfried Wünsche, Sandra D Laufer
1Kompetenzzentrum Drug Design and Target Monitoring, Maria-Göppert-Strasse 1, D-23538 Lübeck, Germany.
Nucleic Acids Research
|October 14, 2006
Summary
Short oligonucleotides show potential as molecular tools and drug leads. A specific hexanucleotide, Hex-S3, effectively inhibits human immunodeficiency virus type 1 (HIV-1) replication by binding to the viral reverse transcriptase.
Area of Science:
- Oligonucleotide therapeutics
- Antiviral drug development
- Molecular biology tools
Background:
- Short oligonucleotides (<10 nt) possess simple structures, making them promising candidates for molecular tools and drug development.
- Optimizing efficacy for short oligonucleotides may be less complex than for longer nucleic acid sequences.
- Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) is a key target for antiviral therapies.
Purpose of the Study:
- To demonstrate the potential of short oligonucleotides as specific molecular tools.
- To investigate the binding of a model hexanucleotide (Hex-S3) to HIV-1 RT.
- To explore the therapeutic potential of Hex-S3 in inhibiting HIV-1 replication.
Main Methods:
- Synthesis and characterization of the hexanucleotide UCGUGU (Hex-S3).
- Ultraviolet (UV) cross-linking studies to assess binding to HIV-1 RT.
- Competition experiments using primer/template substrates and an RT-directed aptamer.
- Cell-based assays to measure the inhibition of HIV-1 replication.
Main Results:
- Hex-S3 demonstrated highly specific binding to the p66 large subunit of HIV-1 RT.
- Binding affinity of Hex-S3 to HIV-1 RT was determined to be 5.3 μM.
- Hex-S3 specifically suppressed HIV-1 replication in human cells by up to three orders of magnitude.
- Evidence suggests Hex-S3 exerts a biologically relevant and specific antiviral activity.
Conclusions:
- Short oligonucleotides, exemplified by Hex-S3, can function as effective molecular tools and potential antiviral agents.
- Hex-S3 represents a novel lead compound for nucleic acid-based drug development against HIV-1.
- Further systematic exploration of hexamer arrays could yield new tools for molecular biology and drug discovery.
Related Concept Videos
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:13Cooperative Binding of Transcription Regulators
Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome. Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
01:29Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...